November 13, 2026 · JAMA · DOI: 10.1001/jama.2026.24689

Fluid eMTBR-tau243 as a Biomarker of Mixed 3-Repeat and 4-Repeat Tau Pathology.

Listen to this summary

This case-control study asked whether biofluid eMTBR-tau243, a mass spectrometry-measured cleaved tau fragment, specifically reflects mixed 3R/4R tau pathology across tauopathies. Across 229 participants, CSF and plasma eMTBR-tau243 were elevated in AD, in symptomatic FTLD-MAPT carriers with mixed 3R/4R pathology, and in high-stage CTE (plasma AUC 0.97 for stages III-IV versus controls), but not in most pure 4R tauopathies such as PSP and CBD. The authors conclude that eMTBR-tau243 may be a promising diagnostic biomarker for CTE and other mixed tauopathies beyond AD, though larger validation cohorts are needed.

Kanta Horie, Rama K Koppisetti, Lawren VandeVrede, Breton M Asken, Yan Li, Daniel Yen, Nupur Ghoshal, Ross W Paterson, Argentina Lario Lago, William W Seeley, Lea T Grinberg, Randall J Bateman, Adam L Boxer, Salvatore Spina, Chihiro Sato

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play